Editorial: Are all eotaxins created equal?

Journal of Leukocyte Biology

Volumn 94, Issue 2, 2013, Pages 207-209

  Pease, James E ^a   Williams, Timothy J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

CCR3; GPCR; Monoclonal antibody

Indexed keywords

EOTAXIN; EOTAXIN 2; EOTAXIN 3; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA;

AIRWAY REMODELING; ASTHMA; CHROMOSOME; DISEASE EXACERBATION; EDITORIAL; EOSINOPHIL; IMMUNOASSAY; LUNG DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE INJURY;

CCR3; GPCR; MONOCLONAL ANTIBODY;

ASTHMA; CHEMOKINE CCL11; CHEMOKINE CCL24; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; EOSINOPHILS; HUMANS; RECEPTORS, CCR3;

EID: 84881004035     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0413189     Document Type: Editorial

References (17)

1. Eltboli, O., Brightling, C. E. (2013) Eosino-phils as diagnostic tools in chronic lung disease. Exp. Rev. Respir. Med. 7, 33-42.
2. Gleich, G. J. (2013) Historical overview of the role of the eosinophil in health and disease. In Eosinophils in Health and Disease, Academic, Elsevier, London, UK.
3. Jose, P. J., Griffiths-Johnson, D. A., Collins, P. D., Walsh, D. T., Moqbel, R., Totty, N. F., Truong, O., Hsuan, J. J., Williams, T. J. (1994) Eotaxin: a potent eosinophil che-moattractant cytokine detected in a guinea pig model of allergic airways inflammation. J. Exp. Med. 179, 881-887.
4. Ponath, P. D., Qin, S., Ringler, D. J., Clark-Lewis, I., Wang, J., Kassam, N., Smith, H., Shi, X., Gonzalo, J. A., Newman, W., Gutiér-rez-Ramos, J. C., Mackay, C. R. (1996) Cloning of the human eosinophil chemoattrac-tant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosino-phils. J. Clin. Invest. 97, 604-612.
5. Fulkerson, P. C., Fischetti, C. A., Mcbride, M. L., Hassman, L. M., Hogan, S. P., Rothenberg, M. E. (2006) A central regulatory role for eosinophils and the eotaxin/ CCR3 axis in chronic experimental allergic airway inflammation. Proc. Natl. Acad. Sci. USA 103, 16418-16423.
6. Forssmann, U., Uguccioni, M., Loetscher, P., Dahinden, C. A., Langen, H., Thelen, M., Baggiolini, M. (1997) Eotaxin-2, a novel CC chemokine that is selective for the chemo-kine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes. J. Exp. Med. 185, 2171-2176.
7. Kitaura, M., Suzuki, N., Imai, T., Takagi, S., Suzuki, R., Nakajima, T., Hirai, K., Nomiyama, H., Yoshie, O. (1999) Molecular cloning of a novel human CC chemokine (eotaxin-3) that is a functional ligand of CC chemokine receptor 3. J. Biol. Chem. 274, 27975-27980.
8. Duchesnes, C. E., Murphy, P. M., Williams, T. J., Pease, J. E. (2006) Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines. Mol. Immunol. 43, 1221-1231.
9. Provost, V., Larose, M. C., Langlois, A., Rola-Pleszczynski, M., Flamand, N., Laviolette, M. (2013) CCL26/eotaxin-3 is more effective to induce the migration of eosinophils of asthmatics than CCL11/eotaxin-1 and CCL24/ eotaxin-2. J. Leukoc. Biol. 94, 512-224.
10. Weber, M., Uguccioni, M., Baggiolini, M., Clark-Lewis, I., Dahinden, C. A. (1996) Deletion of the NH2-terminal residue converts monocyte chemotactic protein 1 from an activator of basophil mediator release to an eosinophil chemoattractant. J. Exp. Med. 183, 681-685.
11. Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., Pease, J. E. (2000) A small molecule antagonist of chemokine receptors CCR1 and CCR3. Potent inhibition of eosin-ophil function and CCR3-mediated HIV-1 entry. J. Biol. Chem. 275, 25985-25992.
12. Kenakin, T. (2011) Functional selectivity and biased receptor signaling. J. Pharmacol. Exp. Ther. 336, 296-302.
13. Hogan, S. P., Rosenberg, H. F., Moqbel, R., Phipps, S., Foster, P. S., Lacy, P., Kay, A. B., Rothenberg, M. E. (2008) Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy. 38, 709-750.
14. Blanchard, C., Wang, N., Stringer, K. F., Mishra, A., Fulkerson, P. C., Abonia, J. P., Jameson, S. C., Kirby, C., Konikoff, M. R., Collins, M. H., Cohen, M. B., Akers, R., Ho-gan, S. P., Assa'ad, A. H., Putnam, P. E., Aronow, B. J., Rothenberg, M. E. (2006) Eo-taxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116, 536-547.
15. Main, S., Handy, R., Wilton, J., Smith, S., Williams, L., Fou, L. D., Andrews, J., Conroy, L. A., May, R., Anderson, I., Vaughan, T. J. (2006) A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacy. J. Pharmacol. Exp. Ther. 319, 1395-1404.
16. Takeda, A., Baffi, J. Z., Kleinman, M. E., Cho, W. G., Nozaki, M., Yamada, K., Kaneko, H., Albuquerque, R. J., Dridi, S., Saito, K., Raisler, B. J., Budd, S. J., Geisen, P., Munitz, A., Ambati, B. K., Green, M. G., Ishibashi, T., Wright, J. D., Humbles, A. A., Gerard, C. J., Ogura, Y., Pan, Y., Smith, J. R., Grisanti, S., Hartnett, M. E., Rothenberg, M. E., Ambati, J. (2009) CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature 460, 225-230.
17. Villeda, S. A., Luo, J., Mosher, K. I., Zou, B., Britschgi, M., Bieri, G., Stan, T. M., Fain-berg, N., Ding, Z., Eggel, A., Lucin, K. M., Czirr, E., Park, J.-S., Couillard-Després, S., Aigner, L., Li, G., Peskind, E. R., Kaye, J. A., Quinn, J. F., Galasko, D. R., Xie, X. S., Rando, T. A., Wyss-Coray, T. (2011) The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 477, 90-94.